Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by KROHN, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KROHN, E. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1972 Oxford University Press

research-article

Epidemiological Aspects of Rubella in Europe*

E. F. KROHN1

1 World Health Organization, Regional Office for Europe Copenhagen, Denmark

Krohn, E. F. (World Health Organization, Regional Office for Europe, Copenhagen, Denmark). Epidemiological aspects of rubella in Europe. Int. J. Epid. 1972, 1 : 267–270.

Rubella acquired after birth is of limited importance to the infected individual. Complications are few and the mortality rate very low. The disease is most frequent in the 1–4 and 5–9 year age groups, 80–90 per cent of adults have antibodies indicating a previous infection.

Clinically manifest rubella during the first months of pregnancy is associated with increased frequencies of foetal deaths and congenital disorders, particularly cardiovascular malformations, cataract and deafness. Congenital malformations have been observed also following clinically inapparent rubella in the mother. It would seen that maternal viremia is the important factor and that artificial immunization will prevent the damage to the foetus to the extent to which it prevents viremia in the infected woman.

Although as many as 10–15 per cent of the women who have clinical rubella during the first months of gestation, and who complete their pregnancy, will give birth to a deformed child, the frequency of congenital malformations caused by the disease is low, probably less than 1 per thousand births, or 5–10 percent of all cases of congenital malformation.

Received 5 May 1972


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.